Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication

J Clin Gastroenterol. 2009 Apr;43(4):384-5. doi: 10.1097/MCG.0b013e31816d921c.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amoxicillin / administration & dosage
  • Amoxicillin / adverse effects
  • Amoxicillin / therapeutic use*
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Ulcer Agents / administration & dosage
  • Anti-Ulcer Agents / adverse effects
  • Anti-Ulcer Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Helicobacter pylori / drug effects*
  • Humans
  • Levofloxacin*
  • Male
  • Middle Aged
  • Ofloxacin / administration & dosage
  • Ofloxacin / adverse effects
  • Ofloxacin / therapeutic use*
  • Omeprazole / administration & dosage
  • Omeprazole / adverse effects
  • Omeprazole / therapeutic use*
  • Patient Compliance
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Levofloxacin
  • Amoxicillin
  • Ofloxacin
  • Omeprazole